Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.
Derangère V, Lecuelle J, Lepage C, Aoulad-Ben Salem O, Allatessem BM, Ilie A, Bouché O, Phelip JM, Baconnier M, Pezet D, Sebbagh V, Terrebonne E, Bouard G, Jooste V, Bouvier AM, Molimard C, Monnien F, Gonzalez D, Le Malicot K, Rageot D, Truntzer C, Bibeau F, Ghiringhelli F; PRODIGE 13 investigators and collaborators.
Derangère V, et al. Among authors: rageot d.
Eur J Cancer. 2022 Sep;172:221-230. doi: 10.1016/j.ejca.2022.05.040. Epub 2022 Jul 1.
Eur J Cancer. 2022.
PMID: 35785606
Free article.